Hesketh L, Wilder C, Ranadive N, Lytra G, Qazimi P, Munro J
Sci Rep. 2020; 10(1):8397.
PMID: 32439959
PMC: 7242333.
DOI: 10.1038/s41598-020-65190-y.
Damasceno D, Ferreira A, Doretto M, Almeida A
Braz J Med Biol Res. 2012; 45(11):1060-5.
PMID: 22801414
PMC: 3854160.
DOI: 10.1590/s0100-879x2012007500119.
Timour Q, Bui-Xuan B, FAUCON G, Aupetit J
Cardiovasc Drugs Ther. 1996; 10(4):447-54.
PMID: 8924058
DOI: 10.1007/BF00051109.
Verdouw P, Wolffenbuttel B
Br J Pharmacol. 1983; 79(1):6-8.
PMID: 6871554
PMC: 2044831.
DOI: 10.1111/j.1476-5381.1983.tb10486.x.
Thandroyen F, Higginson L, Opie L
Basic Res Cardiol. 1981; 76(4):449-52.
PMID: 6269528
DOI: 10.1007/BF01908340.
Alpha adrenergic-mediated accumulation of calcium in reperfused myocardium.
Sharma A, Saffitz J, Lee B, Sobel B, Corr P
J Clin Invest. 1983; 72(3):802-18.
PMID: 6136527
PMC: 1129245.
DOI: 10.1172/JCI111051.
Effect of verapamil and diltiazem on calcium-dependent electrical activity in cardiac Purkinje fibres.
Amerini S, GIOTTI A, Mugelli A
Br J Pharmacol. 1985; 85(1):89-96.
PMID: 4027475
PMC: 1916790.
DOI: 10.1111/j.1476-5381.1985.tb08834.x.
Are calcium antagonists cardioprotective?.
Kendall M, Horton R
J R Coll Physicians Lond. 1985; 19(2):85-9.
PMID: 3889321
PMC: 5371016.
Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.
Opie L
Cardiovasc Drugs Ther. 1988; 1(5):461-91.
PMID: 3154677
DOI: 10.1007/BF02125731.
Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds.
Gulker H, Haverkamp W, Hindricks G, Bender F
Cardiovasc Drugs Ther. 1987; 1(4):367-76.
PMID: 3154673
DOI: 10.1007/BF02209078.
Effects of magnesium on ischemic and reperfusion arrhythmias in the rat heart and electrophysiologic effects of hypermagnesemia in the anesthetized dog.
Keren A, Dorian P, Davy J, Opie L
Cardiovasc Drugs Ther. 1988; 2(5):637-45.
PMID: 3154638
DOI: 10.1007/BF00054203.
Ventricular fibrillation threshold during acute ischemia in hypertrophied rat hearts.
Kohya T, Kimura S, Myerburg R, BASSETT A
Experientia. 1988; 44(3):214-6.
PMID: 2965028
DOI: 10.1007/BF01941709.
Calcium channel antagonists, Part I: Fundamental properties: mechanisms, classification, sites of action.
Opie L
Cardiovasc Drugs Ther. 1987; 1(4):411-30.
PMID: 2856470
DOI: 10.1007/BF02209083.
The antiarrhythmic activity of N-alkyl-1,2-diphenylethanolamines.
El Tahir K, Al-Rashood K, Madani A, Ageel A
Pharm Res. 1989; 6(3):252-4.
PMID: 2726684
DOI: 10.1023/a:1015925803166.
Effects of the calcium antagonist gallopamil on the increase of myocardial extracellular potassium activity during LAD occlusion in dogs.
Budden M, Kirchengast M, Zhang K, MEESMANN W
Basic Res Cardiol. 1987; 82(3):279-89.
PMID: 2443124
DOI: 10.1007/BF01906860.
Antiarrhythmic effects of a benzothiazine derivative (SD-3211) and its stereoisomer (SA3212) in anaesthetized rats and isolated perfused rat hearts compared with bepridil.
Fukuchi M, Uematsu T, Nagashima S, Nakashima M
Naunyn Schmiedebergs Arch Pharmacol. 1990; 341(6):557-64.
PMID: 2392159
DOI: 10.1007/BF00171737.
Spontaneous contractions in rat cardiac trabeculae. Trigger mechanism and propagation velocity.
Daniels M, Ter Keurs H
J Gen Physiol. 1990; 95(6):1123-37.
PMID: 2373999
PMC: 2216350.
DOI: 10.1085/jgp.95.6.1123.
Protective effects of calcium antagonists against ischaemia and reperfusion damage.
Ferrari R, VISIOLI O
Drugs. 1991; 42 Suppl 1:14-26; discussion 26-7.
PMID: 1718690
DOI: 10.2165/00003495-199100421-00005.
Should calcium antagonists be used after myocardial infarction? Ischemia selectivity versus vascular selectivity.
Opie L
Cardiovasc Drugs Ther. 1992; 6(1):19-24.
PMID: 1576093
DOI: 10.1007/BF00050912.
